NCT00046722

Marijuana for HIV-Related Peripheral Neuropathy

Effects of Marijuana on Neuropathic Pain in HIV-Related Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 50 (planned)
• Sponsor: Center for Medicinal Cannabis Research · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.

Detailed description

The study will include subjects with peripheral neuropathy caused either by HIV-disease or antiretroviral medication for the treatment of HIV. A neurologist will conduct a neurological and pain evaluation to determine eligibility for the study. Subjects who meet all eligibility criteria will be admitted to the General Clinical Research Center at San Francisco General Hospital for seven days. Subjects will be randomized (like a toss of a coin) to smoke marijuana or a placebo (cigarettes with no THC).

Conditions

• Peripheral Nervous System Diseases
• HIV Infections

Interventions

Type	Name	Description
DRUG	Smoked Marijuana

Timeline

• Start date: 2003-01-01
• Completion: 2005-04-01
• First posted: 2002-10-03
• Last updated: 2007-06-14

Locations

1 site across 1 country: United States